These results show GRPR activation results in HER4 transactivation in a ROS-dependent manner, which stimulates NSCLC-growth through a MAPK-mediated mechanism, supporting the conclusion that GRPR and HER4 can have important growth effects on NSCLC cells. Here, ERBB4 is linked to non-small cell lung carcinoma.